Back to search

Peptide record

TPDB20060

Antibacterial Anticancer Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20060
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 14-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
GIIKKIIKKIIKKE
Physicochemical Analysis
C79H150N20O17
ARNDCQHLMFPSTWYV
IK
1652.18
10.82
6
1
6
+5
6.11
-0.021
167.14
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
1
G
0
H
6
I
0
L
6
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 6 L: 0 K: 6 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
14
C79H150N20O17
1652.18
10.82
+5
6.11
-0.021
Evidence Records 3 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human chondrocytes-articular cells HCa

Target

Human chondrocytes-articular cells HCa

Source & Reference

NA
DBAASP
Evidence 2 Activity

Activity

0% Hemolysis
Toxicity
500 µM
Hemolytic Cytotoxic
0% Hemolysis | 500 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Surface Physical Activity and Hydrophobicity of Designed Helical Peptide Amphiphiles Control Their Bioactivity and Cell Selectivity. | ACS Appl Mater Interfaces | 2016
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
0 %
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: 0% Hemolysis=500 µM | Cytotoxicity: Not active up to 40 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
ACS Appl Mater Interfaces. 2016 Oct 12 8(40):26501-26510.